Ptc Therapeutics, INC. (PTCT) — 10-Q Filings

10-Q Filings (6)

• PTC Therapeutics Swings to Profit on Soaring Collaboration Revenue — Nov 4, 2025 Risk: medium
  PTC Therapeutics, Inc. reported a significant turnaround for the nine months ended September 30, 2025, achieving a net income of $817.609 million, a substantial
• PTC Therapeutics' Losses Widen Amidst R&D Spend — Aug 7, 2025 Risk: high
  PTC Therapeutics, Inc. reported a net loss of $175.3 million for the three months ended June 30, 2025, a significant increase from the $150.1 million net loss i
• PTC Therapeutics Files Q1 2025 10-Q — May 6, 2025 Risk: medium
  PTC Therapeutics, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quart
• PTC Therapeutics Q3 2024: Revenue Up Slightly, Assets Top $1.6B — Nov 7, 2024 Risk: medium
  PTC Therapeutics, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported total assets of $1.6 billion as of September 30, 2024. For
• PTC Therapeutics Q2 2024 10-Q Filed — Aug 8, 2024 Risk: medium
  PTC Therapeutics, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported total assets of $1.6 billion as of June 30, 2024. This filing pr
• PTC Therapeutics, Inc. Files 10-Q for Period Ending March 31, 2024 — Apr 25, 2024 Risk: medium
  PTC THERAPEUTICS, INC. (PTCT) filed a Quarterly Report (10-Q) with the SEC on April 25, 2024. PTC Therapeutics, Inc. reported financial results for the quarter

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX